Risky business: Challenges in vaccine risk communication

被引：132

作者：

Ball, LK

Evans, G

Bostrom, A

机构：

[1] US FDA, Ctr Biol Evaluat & Res, Off Vaccines Res & Review, Rockville, MD 20852 USA

[2] US Hlth Resources & Serv Adm, Natl Vaccine Injury Compensat Program, Dept Hlth & Human Serv, Rockville, MD 20857 USA

[3] Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA

来源：

PEDIATRICS | 1998年 / 101卷 / 03期

关键词：

D O I：

10.1542/peds.101.3.453

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

[No abstract available]

引用

页码：453 / 458

页数：6

共 52 条

[11]

COLLEY F, 1994, J MANIP PHYSIOL THER, V17, P584

[12]

COULTER HL, 1986, SHOT DARK PARENTS GU

[13]

Covello V.T., 1988, RISK COMMUNICATION R

[14]

Covello VT, 1991, ACCEPTABLE EVIDENCE, P66

[15]

DAWSON NV, 1993, CLIN CHEM, V39, P1468

[16]

Evans G, 1997, RISK COMMUNICATION V

[17] RISK PERCEPTION AND COMMUNICATION [J].

FISCHHOFF, B ;

BOSTROM, A ;

QUADREL, MJ .

ANNUAL REVIEW OF PUBLIC HEALTH, 1993, 14 :183-203

[18]

Fischhoff B., 1983, The analysis of actual versusperceived risks, P235, DOI [10.1007/978-1-4613-3760-7_16, DOI 10.1007/978-1-4613-3760-7_16]

[19] Safety of vaccinations - Miss America, the media, and public health [J].

Freed, GL ;

Katz, SL ;

Clark, SJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (23) :1869-1872

[20]

GOLDSMITH MF, 1992, JAMA-J AM MED ASSOC, V267, P2005

← 1 2 3 4 5 6 →